What’s driving Novo Nordisk’s high dose Wegovy launch Novo Nordisk has moved to launch a higher dose version of Wegovy, continuing its push to expand access and improve outcomes in the growing market for GLP 1 weight loss medicines. The key idea behind higher dosing is that some patients need…
Continue reading...
Continue reading...